Morning Break: Pharma in the Hot Seat; CRISPR Study $$; Google Translate in the ER

Note that some links may require subscriptions.

Seven Big Pharma executives will attend a Senate Finance Committee hearing today. Among the topics discussed? Pricing, patents, and… more pricing. (Politico)

Doctors Without Borders is hosting a webcast Tuesday (12:30 p.m. Eastern time) on the challenges of treating tuberculosis.

Swiss drugmaker Roche will shovel out $4.3 billion to take over U.S.-based gene therapy specialist Spark Therapeutics. (CNBC)

If 70% of U.S. teens are concerned about their peers’ mental health, could that be a product of increased empathy? (The Atlantic)

A Missouri ruling could relieve some of the pressure Johnson & Johnson faces over the safety of its talc-based products. (Reuters)

A slide presentation, a trial registry, and patient consent documents suggest the Chinese government funded the “CRISPR babies” project. (STAT)

Taiho Oncology announced that trifluridine/tipiracil (Lonsurf) received FDA approval for treating metastatic gastric or gastroesophageal junction adenocarcinoma patients who have failed on two prior lines of chemotherapy.

And Bausch + Lomb announced approval of 0.38% loteprednol etabonate ophthalmic gel (Lotemax SM), a new formulation for treating postoperative inflammation and pain after ocular surgery.

What’s the power of a breath of fresh air? Danish study ties childhoods spent near green areas to 55% lower risk of adult psychiatric diagnoses. (PNAS, NPR)

FDA warned a California clinic for marketing an unapproved thermography device for breast cancer screening.

Interested in workforce statistics for long-term care facilities? The CDC has you covered.

Deal or no deal: Regardless of what form Brexit takes, British healthcare will suffer, according to health policy analysts. (Reuters)

Google Translate was 81% accurate for translating emergency department instructions into Chinese; the rate for Spanish was 92%. And in both cases, potentially dangerous mistranslations still occurred. (Gizmodo, JAMA Internal Medicine)

Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: [email protected]